This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) rose 2.59% to $2.77 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.08% to 4,151.94 and Dow Jones Industrial Average falling 0.26% to 32,726.82. This was the stock's third consecutive day of gains. Ocugen Inc. closed $14.88 short of its 52-week high ($17.65), which the company reached on November 3rd.
The stock underperformed when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. (ADVM) rose 8.63% to $1.51, Ocular Therapeutix Inc. (OCUL) rose 3.62% to $4.86, and Kodiak Sciences Inc. (KOD) rose 6.26% to $9.16. Trading volume (5.3 M) remained 906,497 below its 50-day average volume of 6.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 4, 2022.
(END) Dow Jones Newswires
August 04, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.